Skip to main content
SpringerLink
Log in
Book cover

Mechanisms of Sepsis-Induced Organ Dysfunction and Recovery pp 123–135Cite as

Fibrosis in the Acute Respiratory Distress Syndrome

  • Conference paper

  • 1141 Accesses

Part of the Update in Intensive Care and Emergency Medicine book series (UICMSOFT,volume 44)

Keywords

  • Acute Lung Injury
  • Acute Respiratory Distress Syndrome
  • Connective Tissue Growth Factor
  • Respir Crit
  • Tissue Factor Pathway Inhibitor

These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

This is a preview of subscription content, access via your institution.

Chapter
USD   29.95
Price excludes VAT (Canada)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   189.00
Price excludes VAT (Canada)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   249.99
Price excludes VAT (Canada)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   329.99
Price excludes VAT (Canada)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ware LB, Matthay MA (2000) The acute respiratory distress syndrome. N Engl J Med 342:1334–1349

    CrossRef  PubMed  CAS  Google Scholar 

  2. Bellingan GJ (2002) The pulmonary physician in critical care * 6: The pathogenesis of ALI/ARDS. Thorax 57:540–546

    CrossRef  PubMed  CAS  Google Scholar 

  3. Orfanos SE, Mavrommati I, Korovesi I, et al (2004) Pulmonary endothelium in acute lung injury: from basic science to the critically ill. Intensive Care Med 30:1702–1714

    CrossRef  PubMed  CAS  Google Scholar 

  4. Clark JG, Milberg JA, Steinberg KP, et al (1995) Type III procollagen peptide in the adult respiratory distress syndrome. Association of increased peptide levels in bronchoalveolar lavage fluid with increased risk for death. Ann Intern Med 122:17–23

    PubMed  CAS  Google Scholar 

  5. Meduri GU, Headley AS, Golden E, et al (1998) Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA 280:159–165

    CrossRef  PubMed  CAS  Google Scholar 

  6. Chesnutt AN, Matthay MA, Tibayan FA, et al (1997) Early detection of type III procollagen peptide in acute lung injury. Pathogenetic and prognostic significance. Am J Respir Crit Care Med 156:840–845

    PubMed  CAS  Google Scholar 

  7. Marshall RP, Bellingan G, Webb S, et al (2000) Fibroproliferation occurs early in the acute respiratory distress syndrome and impacts on outcome. Am J Respir Crit Care Med 162:1783–1788

    PubMed  CAS  Google Scholar 

  8. Ichikado K, Suga M, Muranaka H, et al (2006) Prediction of prognosis for acute respiratory distress syndrome with thin-section CT: validation in 44 cases. Radiology 238:321–329

    PubMed  Google Scholar 

  9. McAnulty RJ, Laurent GJ (1995) Pathogenesis of lung fibrosis and potential new therapeutic strategies. Exp Nephrol 3:96–107

    PubMed  CAS  Google Scholar 

  10. Chapman HA (2004) Disorders of lung matrix remodeling. J Clin Invest 113:148–157

    CrossRef  PubMed  CAS  Google Scholar 

  11. Madtes DK, Rubenfeld G, Klima LD, et al (1998) Elevated transforming growth factor-alpha levels in bronchoalveolar lavage fluid of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 158:424–430

    PubMed  CAS  Google Scholar 

  12. Snyder LS, Hertz MI, Peterson MS, et al (1991) Acute lung injury. Pathogenesis of intraalveolar fibrosis. J Clin Invest 88:663–673

    CrossRef  PubMed  CAS  Google Scholar 

  13. Miyazaki Y, Araki K, Vesin C, et al (1995) Expression of a tumor necrosis factor-alpha transgene in murine lung causes lymphocytic and fibrosing alveolitis. A mouse model of progressive pulmonary fibrosis. J Clin Invest 96:250–259

    PubMed  CAS  Google Scholar 

  14. Marshall RP, Gohlke P, Chambers RC, et al (2004) Angiotensin II and the fibroproliferative response to acute lung injury. Am J Physiol Lung Cell Mol Physiol 286:L156–L164

    CrossRef  PubMed  CAS  Google Scholar 

  15. Jakubzick C, Choi ES, Joshi BH, et al (2003) Therapeutic attenuation of pulmonary fibrosis via targeting of IL-4-and IL-13-responsive cells. J Immunol 171:2684–2693

    PubMed  CAS  Google Scholar 

  16. Budinger GR, Chandel NS, Donnelly HK, et al (2005) Active transforming growth factorbeta1 activates the procollagen I promoter in patients with acute lung injury. Intensive Care Med 31:121–128

    CrossRef  PubMed  Google Scholar 

  17. Bachofen M, Weibel ER (1982) Structural alterations of lung parenchyma in the adult respiratory distress syndrome. Clin Chest Med 3:35–56

    PubMed  CAS  Google Scholar 

  18. Idell S, Gonzalez K, Bradford H, et al (1987) Procoagulant activity in bronchoalveolar lavage in the adult respiratory distress syndrome. Contribution of tissue factor associated with factor VII. Am Rev Respir Dis 136:1466–1474

    PubMed  CAS  Google Scholar 

  19. Prabhakaran P, Ware LB, White KE, Cross MT, Matthay MA, Ohnan MA (2003) Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injury. Am J Physiol Lung Cell Mol Physiol 285:L20–L28

    PubMed  CAS  Google Scholar 

  20. Fujimoto H, Gabazza EC, Hataji O, et al (2003) Thrombin-activatable fibrinolysis inhibitor and protein C inhibitor in interstitial lung disease. Am J Respir Crit Care Med 167:1687–1694

    CrossRef  PubMed  Google Scholar 

  21. Kirschstein W, Heene DL (1985) Fibrinolysis inhibition in acute respiratory distress syndrome. Scand J Clin Lab Invest Suppl 178:87–94

    PubMed  CAS  Google Scholar 

  22. Ware LB, Fang X, Matthay MA (2003) Protein C and thrombomodulin in human acute lung injury. Am J Physiol Lung Cell Mol Physiol 285:L514–L521

    PubMed  CAS  Google Scholar 

  23. Matthay MA, Ware LB (2004) Plasma protein C levels in patients with acute lung injury: prognostic significance. Crit Care Med 32(Suppl 5):S229–S232

    CrossRef  PubMed  CAS  Google Scholar 

  24. Sabharwal AK, Bajaj SP, Ameri A, et al (1995) Tissue factor pathway inhibitor and von Willebrand factor antigen levels in adult respiratory distress syndrome and in a primate model of sepsis. Am J Respir Crit Care Med 151:758–767

    PubMed  CAS  Google Scholar 

  25. Gando S, Kameue T, Matsuda N, et al (2003) Imbalances between the levels of tissue factor and tissue factor pathway inhibitor in ARDS patients. Thromb Res 109:119–124

    CrossRef  PubMed  CAS  Google Scholar 

  26. Hoffmann H, Siebeck M, Spannagl M, et al (1990) Effect of recombinant hirudin, a specific inhibitor of thrombin, on endotoxin-induced intravascular coagulation and acute lung injury in pigs. Am Rev Respir Dis 142:782–788

    PubMed  CAS  Google Scholar 

  27. Schmidt B, Davis P, La-Pointe H, et al (1996) Thrombin inhibitors reduce intrapulmonary accumulation of fibrinogen and procoagulant activity of bronchoalveolar lavage fluid during acute lung injury induced by pulmonary overdistention in newborn piglets. Pediatr Res 39:798–804

    PubMed  CAS  Google Scholar 

  28. Uchiba M, Okajima K (1997) Antithrombin III (AT III) prevents LPS-induced pulmonary vascular injury: novel biological activity of AT III. Semin Thromb Hemost 23:583–590

    PubMed  CAS  Google Scholar 

  29. Abubakar K, Schmidt B, Monkman S, et al (1998) Heparin improves gas exchange during experimental acute lung injury in newborn piglets. Am J Respir Crit Care Med 158:1620–1625

    PubMed  CAS  Google Scholar 

  30. Piguet PF, Van GY, Guo J (1996) Heparin attenuates bleomycin but not silica-induced pulmonary fibrosis in mice: possible relationship with involvement of myofibroblasts in bleomycin, and fibroblasts in silica-induced fibrosis. Int J Exp Pathol 77:155–116

    CrossRef  PubMed  CAS  Google Scholar 

  31. Yasui H, Gabazza EC, Tamaki S, et al (2001) Intratracheal administration of activated protein C inhibits bleomycin-induced lung fibrosis in the mouse. Am J Respir Crit Care Med 163:1660–1668

    PubMed  CAS  Google Scholar 

  32. Kijiyama N, Ueno H, Sugimoto I, et al (2006) Intratracheal gene transfer of tissue factor pathway inhibitor attenuates pulmonary fibrosis. Biochem Biophys Res Commun 339:1113–1119

    CrossRef  PubMed  CAS  Google Scholar 

  33. Tani K, Yasuoka S, Ogushi F, et al (1991) Thrombin enhances lung fibroblast proliferation in bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol 5:34–40

    PubMed  CAS  Google Scholar 

  34. Vu TK, Hung DT, Wheaton VI, Coughlin SR (1991) Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64:1057–1068

    CrossRef  PubMed  CAS  Google Scholar 

  35. Trejo J, Connolly AJ, Coughlin SR (1996) The cloned thrombin receptor is necessary and sufficient for activation of mitogen-activated protein kinase and mitogenesis in mouse lung fibroblasts. Loss of responses in fibroblasts from receptor knockout mice. J Biol Chem 271: 21536–21541

    CrossRef  PubMed  CAS  Google Scholar 

  36. Chambers RC, Dabbagh K, McAnulty RJ, Gray AJ, Blanc-Brude O, Laurent GJ (1998) Thrombin stimulates fibroblast pro-collagen production via proteolytic activation of protease-activated receptor 1. Biochem J 333:121–127

    PubMed  CAS  Google Scholar 

  37. Chambers RC, Leoni P, Blanc-Brude O, Wembridge DE, Laurent GJ (2000) Thrombin is a potent inducer of connective tissue growth factor production via proteolytic activation of protease-activated receptor-1. J Biol Chem 275:35584–35591

    CrossRef  PubMed  CAS  Google Scholar 

  38. Dery O, Corvera C, Steinhoff M, Bunnett NW (1998) Proteinase-activated receptors:novel mechanisms of signalling by serine proteases. Am J Physiol 274:C1429–C1452

    PubMed  CAS  Google Scholar 

  39. Dawes KE, Gray AJ, Laurent GJ (1993) Thrombin stimulates fibroblast chemotaxis and replication. Eur J Cell Sci 61:126–130

    CAS  Google Scholar 

  40. Chen LB, Buchanan JM (1975) Mitogenic activity of blood components. I. Thrombin and prothrombin. Proc Natl Acad Sci USA 72:131–135

    CrossRef  PubMed  CAS  Google Scholar 

  41. Carney DH, Cunningham DD (1978) Cell surface action of thrombin is sufficient to initiate division of chick cells. Cell 14:811–823

    CrossRef  PubMed  CAS  Google Scholar 

  42. Bogatkevich GS, Tourkina E, Silver RM, et al (2001) Thrombin differentiates normal lung fibroblasts to a myofibroblast phenotype via the proteolytically activated receptor-1 and a protein kinase C-dependent pathway. J Biol Chem 276:45184–45192

    CrossRef  PubMed  CAS  Google Scholar 

  43. Bogatkevich GS, Tourkina E, Abrams CS, et al (2003) Contractile activity and smooth muscle {alpha}-actin organization in thrombin-induced human lung myofibroblasts. Am J Physiol Lung Cell Mol Physiol 285:L334–L343

    PubMed  CAS  Google Scholar 

  44. Dabbagh K, Laurent GJ, McAnulty RJ, et al (1998) Thrombin stimulates smooth muscle cell procollagen synthesis and mRNA levels via a PAR-1 mediated mechanism. Thromb Haemost 79:405–409

    PubMed  CAS  Google Scholar 

  45. Blanc-Brude OP, Archer F, Leoni P, et al (2005) Factor Xa stimulates fibroblast procollagen production, proliferation, and calcium signaling via PAR1 activation. Exp Cell Res 304:16–27

    CrossRef  PubMed  CAS  Google Scholar 

  46. Hernandez-Rodriguez NA, Cambrey AD, Harrison NK, et al (1995) Role of thrombin in pulmonary fibrosis. Lancet 346:1071–1073

    CrossRef  PubMed  CAS  Google Scholar 

  47. Ohba T, McDonald JK, Silver RM (1994) Scleroderma bronchoalveolar lavage fluid contains thrombin, a mediator of human lung fibroblast proliferation via induction of platelet-derived growth factor alpha-receptor. Am J Respir Cell Mol Biol 10:405–412

    PubMed  CAS  Google Scholar 

  48. Howell DC, Goldsack NR, Marshall RP, et al (2001) Direct thrombin inhibition reduces lung collagen, accumulation, and connective tissue growth factor mRNA levels in bleomycininduced pulmonary fibrosis. Am J Pathol 159:1383–1395

    PubMed  CAS  Google Scholar 

  49. Howell DC, Johns RH, Lasky JA, et al (2005) Absence of proteinase-activated receptor-1 signaling affords protection from bleomycin-induced lung inflammation and fibrosis. Am J Pathol 166:1353–1365

    PubMed  CAS  Google Scholar 

  50. Macfarlane SR, Seatter MJ, Kanke T, et al (2001) Proteinase-activated receptors. Pharmacol Rev 53:245–282

    PubMed  CAS  Google Scholar 

  51. Blanc-Brude OP, Chambers RC, Leoni P, Dik WA, Laurent GJ (2001) Factor Xa is a fibroblast mitogen via binding to effector-cell protease receptor-1 and autocrine release of PDGF. Am J Physiol Cell Physiol 281:C681–C689

    PubMed  CAS  Google Scholar 

  52. Pendurthi UR, Ngyuen M, Andrade-Gordon P (2002) Plasmin induces Cyr61 gene expression in fibroblasts via protease-activated receptor-1 and p44/42mitogen-activated protein kinasedependent signalling pathway. Arterioscler Thromb Vasc Biol 22:1421–1426

    CrossRef  PubMed  CAS  Google Scholar 

  53. Riewald M, Ruf W (2001) Mechanistic coupling of protease signalling and initiation of coagulation by tissue factor. Proc Natl Acad Sci USA 98:7742–7747

    CrossRef  PubMed  CAS  Google Scholar 

  54. O’Brien PJ, Molino M, Kahn M, et al (2001) Protease activated receptors: theme and variations. Oncogene 20:1570–1581

    CrossRef  PubMed  CAS  Google Scholar 

  55. Camerer E, Huang W, Coughlin SR (2000) Tissue factor-and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. Proc Natl Acad Sci USA 97:5255–5260

    CrossRef  PubMed  CAS  Google Scholar 

  56. Nakayama T, Hirano K, Shintani Y, et al (2003) Unproductive cleavage and the inactivation of protease-activated receptor-1 by trypsin in vascular endothelial cells. Br J Pharmacol 138:121–130

    CrossRef  PubMed  CAS  Google Scholar 

  57. Suzuki T, Moraes TJ, Vachon E, et al (2005) Proteinase-activated receptor-1 mediates elastaseinduced apoptosis of human lung epithelial cells. Am J Respir Cell Mol Biol 33:231–247

    CrossRef  PubMed  CAS  Google Scholar 

  58. Laurent GJ (2005) No bit PARt for PAR-1. Am J Respir Cell Mol Biol 33:213–215

    CrossRef  PubMed  CAS  Google Scholar 

  59. Riewald M, Petrovan RJ, Donner A, et al (2002) Activation of endothelial cell protease activated receptor 1 by the protein C pathway. Science 296:1880–1882

    CrossRef  PubMed  CAS  Google Scholar 

  60. Ruf W, Riewald M (2003) Tissue factor-dependent coagulation protease signalling in acute lung injury. Crit Care Med 31(Suppl 4): S231–S237

    CrossRef  PubMed  CAS  Google Scholar 

  61. Bernard GR, Vincent JL, Laterre PF, et al (2001) Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344:699–709

    CrossRef  PubMed  CAS  Google Scholar 

  62. Ruf W (2005) Is APC activation of endothelial cell PAR1 important in severe sepsis?: Yes. J Thromb Haemost 3:1912–1914

    CrossRef  PubMed  CAS  Google Scholar 

  63. Esmon CT (2005) Is APC activation of endothelial cell PAR1 important in severe sepsis?: No. J Thromb Haemost 3:1910–1911

    CrossRef  PubMed  CAS  Google Scholar 

  64. Pawlinski R, Pedersen B, Schabbauer G, et al (2004) Role of tissue factor and protease-activated receptors in a mouse model of endotoxemia. Blood 103:1342–1347

    CrossRef  PubMed  CAS  Google Scholar 

  65. Camerer E, Cornelissen I, Kataoka H, et al (2006) Roles of protease-activated receptors in a mouse model of endotoxemia. Blood 107:3912–3921

    CrossRef  PubMed  CAS  Google Scholar 

  66. Brass LF (1997) Thrombin receptor antagonists: a work in progress. Coron Artery Dis 8:49–58

    PubMed  CAS  Google Scholar 

  67. Bernatowicz MS, Klimas CE, Hartl KS, Peluso M, Allegretto NJ, Seiler SM (1996) Development of potent thrombin receptor antagonist peptides. J Med Chem 39:4879–4887

    CrossRef  PubMed  CAS  Google Scholar 

  68. Andrade-Gordon P, Derian CK, Maryanoff BE, et al (2001) Administration of a potent antagonist of protease-activated receptor-1 (PAR-1) attenuates vascular restenosis following balloon angioplasty in rats. J Pharmacol Exp Ther 298:34–42

    PubMed  CAS  Google Scholar 

  69. Derian CK, Damiano BP, Addo MF (2003) Blockade of the thrombin receptor protease-activated receptor-1 with a small-molecule antagonist prevents thrombus formation and vascular occlusion in nonhuman primates. J Pharmacol Exp Ther 304:855–861

    CrossRef  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for Respiratory Research, The Rayne Institute, 5 University Street, London, WC1E 6JJ, UK

    D. C. J. Howell, R. C. Chambers & G. J. Laurent

Authors
  1. D. C. J. Howell
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. C. Chambers
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. J. Laurent
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Health Sciences Center, Division Pulmonary & Critical Care Medicine, University of Colorado, E. Ninth Avenue 4200, 80262, Denver, CO, USA

    Edward Abraham MD

  2. Bloomsbury Institute of Intensive Care, Division Medicine, University College Hospital, Gower Street, WC1E 6BT, London, UK

    Mervyn Singer MD

Rights and permissions

Reprints and Permissions

Copyright information

© 2007 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Howell, D.C.J., Chambers, R.C., Laurent, G.J. (2007). Fibrosis in the Acute Respiratory Distress Syndrome. In: Abraham, E., Singer, M. (eds) Mechanisms of Sepsis-Induced Organ Dysfunction and Recovery. Update in Intensive Care and Emergency Medicine, vol 44. Springer, Berlin, Heidelberg . https://doi.org/10.1007/3-540-30328-6_9

Download citation

  • DOI: https://doi.org/10.1007/3-540-30328-6_9

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-30157-8

  • Online ISBN: 978-3-540-30328-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

search

Navigation